Literature DB >> 7001171

Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease.

C L Conley, J Misiti, A J Laster.   

Abstract

Among 320 relatives of 28 patients with chronic lymphocytic leukemia (CLL), 4 had CLL, 1 had lymphosarcoma, and 2 other adults had leukemia of unknown type. Autoimmune disease including hyperthyroidism, pernicious anemia, rheumatoid arthritis and systemic lupus erythematosus affected 18 relatives. HLA typing of members of two families demonstrated that within each family the patient with CLL shared a common haplotype with relatives with autoimmune disease, but the haplotype was different in the two kindreds. In contrast, CLL was encountered in only 1 and autoimmune disease in 4 of 396 relatives of a group of 28 control patients. These data together with information from earlier reports support the hypothesis that genetic factors distrubing the regulation of the immune system may predispose both to lymphoid neoplasms and to autoimmune disease. The concept is supported by an array of experimental studies in animals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001171     DOI: 10.1097/00005792-198009000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  10 in total

1.  Development of chronic lymphocytic leukaemia after posttraumatic splenectomy.

Authors:  J Demeter; K Pálóczi; P Vargha; D Lehoczky
Journal:  Blut       Date:  1990-06

2.  Cancer mortality of family members of patients with chronic lymphocytic leukemia.

Authors:  Z Radovanovic; L Markovic-Denic; S Jankovic
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

Review 3.  Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors:  Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal:  Haematologica       Date:  2011-01-17       Impact factor: 9.941

4.  Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals.

Authors:  A M Stall; M C Fariñas; D M Tarlinton; P A Lalor; L A Herzenberg; S Strober; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Splenic lymphoma with circulating villous lymphocytes.

Authors:  F Imbing; D Kumar; S Kumar; G Yuoh; F Gardner
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

6.  Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Authors:  Ola Landgren; Eric A Engels; Neil E Caporaso; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

7.  Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia.

Authors:  Jennifer A Kelly; Kevin Thompson; Jeff Kilpatrick; Tom Lam; Swapan K Nath; Courtney Gray-McGuire; Jeff Reid; Bahram Namjou; Christopher E Aston; Gail R Bruner; R Hal Scofield; John B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

8.  Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy.

Authors:  T J Kipps; E Tomhave; P P Chen; D A Carson
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

9.  Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.

Authors:  R A Cartwright; S M Bernard; C C Bird; C M Darwin; C O'Brien; I D Richards; B Roberts; P A McKinney
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

10.  H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.

Authors:  H Okamoto; H Nishimura; A Shinozaki; D Zhang; S Hirose; T Shirai
Journal:  Jpn J Cancer Res       Date:  1993-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.